Otalvaro, J. D.
Yamada, W. M.
Hernandez, A. M.
Zuluaga, A. F.
Chen, R.
Neely, M. N.
Article History
Received: 19 August 2022
Accepted: 13 October 2022
First Online: 7 December 2022
Declarations
:
: A. F. Zuluaga has received honoraria for unrelated lectures from Allergan, Amgen, Bayer, Celltrion, Janssen, Lilly, Novartis, Novo Nordisk, Pfizer, Roche, and Sanofi. Rodriguez has also received honoraria for unrelated lectures from Allergan, Biosidus, Novo Nordisk, and Novartis. None of these companies or any other pharmaceutical company was involved in the design, execution, or publication of this study. The remaining authors declare no conflict of interest.